SeekingAlpha · Oct 5, 2026
Surf Air Mobility: Aviation Cash Burn Is Outpacing The Software Story
Surf Air Mobility Inc. is rated a Sell due to cash burn, dilution, and low profitability. Read more on SRFM stock here.
SR
NASDAQ · SRTA
Strata Critical Medical, Inc.
Industrials · Airlines, Airports & Air Services
$4.68
Down-$0.11 (-2.24%)
Updated Oct 8, 2026, 6:15 PM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 454.25M
- P/E ratio
- 10.74
- Dividend yield
- 0.00%
- 52-week range
- $3.95 – $6.50
- Volume
- 703.94K
- Avg. volume
- 907.57K
Price performance · SRTA
SRTA price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
SRTA closed at $4.68 after 21 trading sessions, down 10.34% for the selected period.
- Last close
- $4.68
- Period change
- -10.34%
- Period low
- $4.68
- Period high
- $5.48
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $4.74 | $4.74 | $4.65 | $4.68 | 703.94K |
| Oct 6, 2026 | $4.84 | $4.855 | $4.72 | $4.75 | 760.51K |
| Oct 5, 2026 | $4.76 | $4.91 | $4.685 | $4.81 | 1.16M |
| Oct 2, 2026 | $4.90 | $4.925 | $4.71 | $4.73 | 999.67K |
| Oct 1, 2026 | $5.12 | $5.12 | $4.795 | $4.83 | 1.61M |
| Sep 30, 2026 | $5.13 | $5.175 | $5.079 | $5.11 | 798.32K |
| Sep 29, 2026 | $5.29 | $5.34 | $5.01 | $5.10 | 1.22M |
| Sep 28, 2026 | $5.25 | $5.30 | $5.135 | $5.23 | 654.36K |
| Sep 25, 2026 | $5.28 | $5.40 | $5.2001 | $5.33 | 519.61K |
| Sep 24, 2026 | $5.33 | $5.41 | $5.23 | $5.27 | 618.83K |
| Sep 23, 2026 | $5.43 | $5.52 | $5.305 | $5.38 | 895.53K |
| Sep 22, 2026 | $5.46 | $5.50 | $5.33 | $5.48 | 666.41K |
| Sep 21, 2026 | $5.40 | $5.47 | $5.32 | $5.40 | 573.61K |
| Sep 18, 2026 | $5.40 | $5.488 | $5.235 | $5.34 | 896.49K |
| Sep 17, 2026 | $5.30 | $5.415 | $5.285 | $5.38 | 571.56K |
| Sep 16, 2026 | $5.30 | $5.345 | $5.13 | $5.22 | 525.81K |
| Sep 15, 2026 | $5.31 | $5.3982 | $5.20 | $5.29 | 546.31K |
| Sep 14, 2026 | $5.11 | $5.42 | $5.11 | $5.36 | 1.15M |
| Sep 11, 2026 | $5.19 | $5.325 | $5.15 | $5.195 | 770.73K |
| Sep 10, 2026 | $5.20 | $5.33 | $5.10 | $5.13 | 797.12K |
| Sep 9, 2026 | $5.25 | $5.31 | $5.20 | $5.22 | 768.73K |
Latest SRTA news
The latest Smart Investors Daily articles mentioning SRTA.
Stock researchCompany · Overview
Company
Market Activity
Research & News
SRTA research
Overview
Company profile and research snapshot.
Company profile
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $7.25
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 25, 2026 | B. Riley Securities | Buy | — |
| Mar 25, 2026 | Craig-Hallum | Buy | — |
| Sep 17, 2025 | Lake Street | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Sep 28, 2026
Strata Critical Medical Q2 2026 Earnings Call Transcript
Strata Critical Medical (NASDAQ:SRTA) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive
SeekingAlpha · Sep 16, 2026
Strata Critical Medical: Pivot To M&A Offers Near-Term Upside, But TAM Constraints Remain
Strata Critical Medical is executing a roll-up strategy, acquiring clinical assets at low multiples to drive inorganic growth. Find out why SRTA stock is a hold.
SeekingAlpha · Sep 10, 2026
Tracking Dan Loeb's Third Point Portfolio - Q2 2026 Update
Third Pointâs Q2 2026 13F: portfolio doubled to $4.68B as WBD becomes top holding; new buys include Keysight, Block; exits Meta/Nvidia. See more here.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
